Clinical trials
Recruiting Adenocarcinoma of Lung trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Pulmonary Hospital, Shanghai, China | 6 |
| Fudan University | 5 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| AstraZeneca | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Hebei Medical University Fourth Hospital | 1 |
| Hunan Province Tumor Hospital | 1 |
| Pfizer | 1 |
| Sichuan Cancer Hospital and Research Institute | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 20 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Ovarian Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Transitional Cell | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.